Abstract: Disclosed herein are glycan-coated RBD immunogens, engineered nanoparticle vaccines comprising glycan-coated RBD immunogens and methods of use thereof for SARS-COV-2 vaccines.

Abstract: Disclosed herein are nanoparticles comprising one or more Human papillomavirus (HPV) antigen and nucleic acid molecules encoding the same. Also disclosed herein is a method of treating a HPV infection or treating or preventing a disease or disorder associated therewith in a subject in need thereof, by administering the nanoparticles, or encoding nucleic acid molecules, to the subject.

Abstract: A printer according to an embodiment includes a printing unit that prints on a sheet. The sheet is discharged through an outlet. The sheet is conveyed on a sheet conveyance path through the printing unit and to the outlet. A movable device is located on the sheet conveyance path upstream of the outlet in a sheet conveying direction. The movable device can move between a separation position, a proximity position, and a protruding position. A detection device detects a position of the movable device. A controller determines a conveyance abnormality of the sheet based on the state of the movable device detected by the detection device, and outputs a signal indicating the conveyance abnormality.

Abstract: A printer according to an embodiment includes a printing unit that prints on a sheet. The sheet is discharged through an outlet. The sheet is conveyed on a sheet conveyance path through the printing unit and to the outlet. A movable device is located on the sheet conveyance path upstream of the outlet in a sheet conveying direction. The movable device can move between a separation position, a proximity position, and a protruding position. A detection device detects a position of the movable device. A controller determines a conveyance abnormality of the sheet based on the state of the movable device detected by the detection device, and outputs a signal indicating the conveyance abnormality.